Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Bsteh

Showing results (91-100 of 169) with videos related to

Pageof 17
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 30, 2017
Change of olfactory function as a marker of inflammatory activity and disability progression in MSGabriel Bsteh, Harald Hegen, Felix Ladstätter, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 16, 2020
Retinal layer thinning is reflecting disability progression independent of relapse activity in multiple sclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
CNS Drugs|September 29, 2022
Soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1) and Natalizumab Serum Concentration as Potential Biomarkers for Pharmacodynamics and Treatment Response of Patients with Multiple Sclerosis Receiving NatalizumabMichael Auer, Angelika Bauer, Antonia Oftring, et al.
The Journal of Sexual Medicine|March 21, 2021
Sexuality and Multiple Sclerosis: Patient and Doctor PerspectivesPatrick Altmann, Katharina Leithner, Fritz Leutmezer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 6, 2025
Dissecting definitions of disability accrual in relapsing multiple sclerosis-Have we reached standardization yet?Gabriel Bsteh, Stefanie Marti, Helly Hammer, et al.
Wiener Klinische Wochenschrift|January 12, 2026
The Austrian MS database and the Austrian MS cohort : A national effort towards data harmonization and prospective data collectionGabriel Bsteh, Fabian Föttinger, Markus Ponleitner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 3, 2020
Macular ganglion cell-inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosisGabriel Bsteh, Klaus Berek, Harald Hegen, et al.
Frontiers in Neurology|February 26, 2021
Predisposing Factors for Sexual Dysfunction in Multiple SclerosisPatrick Altmann, Fritz Leutmezer, Katharina Leithner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 22, 2019
Impairment of odor discrimination and identification is associated with disability progression and gray matter atrophy of the olfactory system in MSGabriel Bsteh, Ruth Steiger, Noora Tuovinen, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 15, 2019
Serum neurofilament light levels correlate with change of olfactory function in multiple sclerosisGabriel Bsteh, Klaus Berek, Harald Hegen, et al.
Pageof 17

Showing results (91-100 of 169) with videos related to

Sort By:
Pageof 17
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 30, 2017
Change of olfactory function as a marker of inflammatory activity and disability progression in MSGabriel Bsteh, Harald Hegen, Felix Ladstätter, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 16, 2020
Retinal layer thinning is reflecting disability progression independent of relapse activity in multiple sclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
CNS Drugs|September 29, 2022
Soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1) and Natalizumab Serum Concentration as Potential Biomarkers for Pharmacodynamics and Treatment Response of Patients with Multiple Sclerosis Receiving NatalizumabMichael Auer, Angelika Bauer, Antonia Oftring, et al.
The Journal of Sexual Medicine|March 21, 2021
Sexuality and Multiple Sclerosis: Patient and Doctor PerspectivesPatrick Altmann, Katharina Leithner, Fritz Leutmezer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 6, 2025
Dissecting definitions of disability accrual in relapsing multiple sclerosis-Have we reached standardization yet?Gabriel Bsteh, Stefanie Marti, Helly Hammer, et al.
Wiener Klinische Wochenschrift|January 12, 2026
The Austrian MS database and the Austrian MS cohort : A national effort towards data harmonization and prospective data collectionGabriel Bsteh, Fabian Föttinger, Markus Ponleitner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 3, 2020
Macular ganglion cell-inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosisGabriel Bsteh, Klaus Berek, Harald Hegen, et al.
Frontiers in Neurology|February 26, 2021
Predisposing Factors for Sexual Dysfunction in Multiple SclerosisPatrick Altmann, Fritz Leutmezer, Katharina Leithner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 22, 2019
Impairment of odor discrimination and identification is associated with disability progression and gray matter atrophy of the olfactory system in MSGabriel Bsteh, Ruth Steiger, Noora Tuovinen, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 15, 2019
Serum neurofilament light levels correlate with change of olfactory function in multiple sclerosisGabriel Bsteh, Klaus Berek, Harald Hegen, et al.
Pageof 17